• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Central involvement of SARS-CoV-2 may aggravate ARDS and hypertension.

作者信息

Cure Erkan, Cumhur Cure Medine, Vatansev Hulya

机构信息

Department of Internal Medicine, Ota & Jinemed Hospital, Istanbul, Turkey.

Department of Biochemistry, Private Practice, Istanbul, Turkey.

出版信息

J Renin Angiotensin Aldosterone Syst. 2020 Oct-Dec;21(4):1470320320972015. doi: 10.1177/1470320320972015.

DOI:10.1177/1470320320972015
PMID:33169637
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7658518/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7512/7658518/ca23a50fee00/10.1177_1470320320972015-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7512/7658518/ca23a50fee00/10.1177_1470320320972015-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7512/7658518/ca23a50fee00/10.1177_1470320320972015-fig1.jpg

相似文献

1
Central involvement of SARS-CoV-2 may aggravate ARDS and hypertension.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的中枢神经系统受累可能会加重急性呼吸窘迫综合征（ARDS）和高血压。
J Renin Angiotensin Aldosterone Syst. 2020 Oct-Dec;21(4):1470320320972015. doi: 10.1177/1470320320972015.
2
Countermeasure and therapeutic: A(1-7) to treat acute respiratory distress syndrome due to COVID-19 infection.对策与治疗：A(1 - 7)用于治疗由COVID - 19感染引起的急性呼吸窘迫综合征。
J Renin Angiotensin Aldosterone Syst. 2020 Oct-Dec;21(4):1470320320972018. doi: 10.1177/1470320320972018.
3
SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis.严重急性呼吸综合征冠状病毒2型发病机制：肾素-血管紧张素系统失衡促进肺纤维化。
Front Cell Infect Microbiol. 2020 Jun 12;10:340. doi: 10.3389/fcimb.2020.00340. eCollection 2020.
4
COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure.心力衰竭背景下COVID-19对肾素-血管紧张素系统的干扰
mBio. 2020 May 22;11(3):e00946-20. doi: 10.1128/mBio.00946-20.
5
ACE2 and COVID-19 and the resulting ARDS.血管紧张素转化酶 2 与 COVID-19 及由此导致的急性呼吸窘迫综合征。
Postgrad Med J. 2020 Jul;96(1137):403-407. doi: 10.1136/postgradmedj-2020-137935. Epub 2020 Jun 10.
6
COVID-19 and the pulmonary vascular injury.新型冠状病毒肺炎与肺血管损伤
J Renin Angiotensin Aldosterone Syst. 2020 Oct-Dec;21(4):1470320320972276. doi: 10.1177/1470320320972276.
7
Use of Renin-Angiotensin System Blockers During the COVID-19 Pandemic: Early Guidance and Evolving Evidence.2019冠状病毒病大流行期间肾素-血管紧张素系统阻滞剂的使用：早期指南及不断演变的证据
Can J Cardiol. 2020 Aug;36(8):1180-1182. doi: 10.1016/j.cjca.2020.05.033. Epub 2020 Jun 2.
8
Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System: JACC Review Topic of the Week.SARS-CoV-2 与肾素血管紧张素系统相互作用的临床意义：美国心脏病学会评论专题周报。
J Am Coll Cardiol. 2020 Jun 23;75(24):3085-3095. doi: 10.1016/j.jacc.2020.04.028. Epub 2020 Apr 16.
9
MIS-C After ARDS Associated With SARS-CoV-2.儿童多系统炎症综合征（MIS-C）继发于 SARS-CoV-2 相关的急性呼吸窘迫综合征（ARDS）。
Pediatr Infect Dis J. 2020 Nov;39(11):e363-e365. doi: 10.1097/INF.0000000000002879.
10
COVID-19 and the kidney.新型冠状病毒肺炎与肾脏。
Cleve Clin J Med. 2020 Oct 1;87(10):619-631. doi: 10.3949/ccjm.87a.20072.

引用本文的文献

1
Acute respiratory distress syndrome: potential of therapeutic interventions effective in treating progression from COVID-19 to treat progression from other illnesses-a systematic review.急性呼吸窘迫综合征：治疗 COVID-19 进展的潜在治疗干预措施对治疗其他疾病进展的有效性-系统评价。
BMJ Open Respir Res. 2023 Sep;10(1). doi: 10.1136/bmjresp-2022-001525.
2
Vaccines against SARS-CoV-2 variants and future pandemics.针对 SARS-CoV-2 变体和未来大流行的疫苗。
Expert Rev Vaccines. 2022 Oct;21(10):1363-1376. doi: 10.1080/14760584.2022.2110075. Epub 2022 Aug 12.
3
Strong relationship between cholesterol, low-density lipoprotein receptor, Na/H exchanger, and SARS-COV-2: this association may be the cause of death in the patient with COVID-19.

本文引用的文献

1
The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier.SARS-CoV-2 刺突蛋白改变了二维静态和三维微流控体外血脑屏障模型中的屏障功能。
Neurobiol Dis. 2020 Dec;146:105131. doi: 10.1016/j.nbd.2020.105131. Epub 2020 Oct 11.
2
A prospective clinical study of detailed neurological manifestations in patients with COVID-19.一项关于 COVID-19 患者详细神经表现的前瞻性临床研究。
Neurol Sci. 2020 Aug;41(8):1991-1995. doi: 10.1007/s10072-020-04547-7. Epub 2020 Jun 25.
3
Comment on "Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?".
胆固醇、低密度脂蛋白受体、钠/氢交换体与 SARS-COV-2 之间的强关联：这种关联可能是 COVID-19 患者死亡的原因。
Lipids Health Dis. 2021 Dec 13;20(1):179. doi: 10.1186/s12944-021-01607-5.
4
Effects of the Na/H Ion Exchanger on Susceptibility to COVID-19 and the Course of the Disease.钠/氢离子交换器对新型冠状病毒肺炎易感性及病程的影响。
J Renin Angiotensin Aldosterone Syst. 2021 Jun 15;2021:4754440. doi: 10.1155/2021/4754440. eCollection 2021.
关于《一种用于治疗新冠肺炎的旧疟疾药物：平稳推进还是冒险尝试？》的评论
J Neuroimmune Pharmacol. 2020 Sep;15(3):345-346. doi: 10.1007/s11481-020-09938-3. Epub 2020 Jun 25.
4
Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid.急性坏死性脑病伴 SARS-CoV-2 RNA 确证的脑脊液。
Neurology. 2020 Sep 8;95(10):445-449. doi: 10.1212/WNL.0000000000010250. Epub 2020 Jun 25.
5
Impaired Breakdown of Bradykinin and Its Metabolites as a Possible Cause for Pulmonary Edema in COVID-19 Infection.缓激肽及其代谢产物分解受损可能是新冠病毒感染导致肺水肿的原因
Semin Thromb Hemost. 2020 Oct;46(7):835-837. doi: 10.1055/s-0040-1712960. Epub 2020 Jun 11.
6
Comment on "The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients".评“SARS-CoV-2 的神经侵袭性可能在 COVID-19 患者呼吸衰竭中起作用”一文。
J Med Virol. 2020 Jul;92(7):703-704. doi: 10.1002/jmv.25960. Epub 2020 May 22.
7
Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.COVID-19 患者的激肽释放酶-激肽系统阻断治疗以预防急性呼吸窘迫综合征。
Elife. 2020 Apr 27;9:e57555. doi: 10.7554/eLife.57555.
8
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic.在新冠疫情期间，血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂可能对糖尿病患者有害。
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):349-350. doi: 10.1016/j.dsx.2020.04.019. Epub 2020 Apr 15.
9
Comment on "Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19".关于《血管紧张素转换酶2的器官保护作用及其对新型冠状病毒肺炎预后的影响》的评论
J Med Virol. 2020 Sep;92(9):1423-1424. doi: 10.1002/jmv.25848. Epub 2020 Jun 2.
10
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.新冠病毒病患者中的肾素-血管紧张素-醛固酮系统抑制剂
N Engl J Med. 2020 Apr 23;382(17):1653-1659. doi: 10.1056/NEJMsr2005760. Epub 2020 Mar 30.